10X Genomics Inc is experiencing a positive surge in its stock price, reflecting investor confidence amidst favorable market conditions.
10X Genomics Inc (NASDAQ:TXG) is rising today, up by 1.55% as investors react positively to broader trends in the healthcare sector. The stock's upward movement aligns with a general increase in healthcare stocks, which has been noted in recent market updates.
Investor takeaway: The rise in 10X Genomics' stock price suggests growing investor confidence in the company's potential, especially in light of positive sector trends. However, investors should remain cautious given the company's recent reductions in exposure by major funds like Ark Invest.
Advertisement
10X Genomics Inc
TXG.US
TXG.US
10X Genomics Inc
WealthAwesomeMarket cap
$11.53B
52W high
$89.95
52W low
$11.16
1W change
+11.88%
Beta
2.08
Analyst Price Targets
Based on 16 analysts covering TXG · as of Sep 29, 2026
Wall Street analysts forecast TXG stock price to fall 33.6% over the next 12 months.
Consensus
Buy3.75 / 5.00
Avg. Target
C$58.80
-33.6% Upside
Previously C$56.60 on Sep 23, 2026
Current Price
C$88.50
Last close
Analyst Breakdown (16 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TXG's historical volatility
30-Day Vol
63.5%
Annualized
90-Day Vol
72.6%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$105.80
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$93.93 | C$75.44 – C$116.95 |
| 60 trading days | C$99.69 | C$73.11 – C$135.92 |
| 90 trading days | C$105.80 | C$72.37 – C$154.67 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
1.55% Increase in Stock Price
10X Genomics' stock price closed at CA$89.87, reflecting a modest but significant gain amidst a supportive healthcare market environment.
Bull case
The strong performance of healthcare stocks could indicate a recovery or growth phase for companies like 10X Genomics. This may lead to increased demand for its genomic technologies and products. The company's innovative solutions in genomics position it well for future growth.
Bear case
Despite the recent gains, 10X Genomics faces challenges, including a negative profit margin and notable selling pressure from institutional investors. The reduction of holdings by Ark Invest may signal a lack of confidence in the stock's short-term prospects.
Market Context
Advertisement
The healthcare sector has seen a notable rise, with indices reflecting increased investor interest. This trend has positively impacted stocks like 10X Genomics, which operates within the biotechnology space. The overall market sentiment suggests a potential rebound in healthcare investments.
Institutional Investor Activity
Despite the positive market movement, recent reports indicate that Ark Invest has reduced its position in 10X Genomics. This action may raise concerns among investors about the company's short-term outlook, highlighting the need for caution despite today's gains.
Future Prospects
Looking ahead, 10X Genomics' innovative technologies in genomics could position it favorably for growth, especially as the demand for genomic solutions continues to rise. However, investors should monitor the company's financial health and market pressures closely.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
